About RECOMBINANT TECHNOLOGIES LLC
Recombinant Technologies is a privately held, development-stage biotechnology company focused on developing therapeutics for neurodegenerative diseases, particularly Alzheimer's. The company was founded in 1999 and has received multiple SBIR grants from the National Institutes of Health.
Development of small molecules to treat Alzheimer's diseaseProof-of-concept testing of proprietary small moleculesPreclinical studies for IND-enabling studiesDevelopment of AmyTrapper™ plasma-filtration column for clinical application
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to RECOMBINANT TECHNOLOGIES LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.